Syntroleum Corporation (SYNM)

[Dcon]

I have to admit it is moving up . here is why.

http://custom.fmg.dowjones.com/custom/tdameritrade-com/html-story.asp?guid={a3eb7b21-e8f1-41e3-85b4-9eab289a4caa}


Research Reports on Top Traded Penny Stocks: Hanmi Financial, Geron, Towerstream, BioSante, Syntroleum & SunwinLast update: 11/16/2011 8:50:00 AMVANCOUVER, British Columbia, Nov. 16, 2011 /PRNewswire via COMTEX/ -- Pennystocksinsiders.com

(PSI) has issued insider trading reports and Equity Research for the following companies:

Hanmi Financial (HAFC),
Geron (GERN),
Towerstream (TWER),
BioSante (BPAX),
Syntroleum (SYNM) &
Sunwin (SUWN).

Investors can easily trade penny stocks online now. Many online stock brokers provide free equity research reports for their clients; however, none of them provides insider trading research reports. Penny stock companies are lack of transparency and almost no investment firm research analysts regularly issue research reports for penny stocks. Monitoring the insider trading activities may be one of a few ways to find out more information about penny stock companys' real financial situation. (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights: Hanmi Financial Corp (HAFC): Stock price dropped over 8% on Nov 15, 2011 on heavier than usual volume. Why? Did insiders like CEOs, CFOs, and Directors sell their shareholdings before the stock price dropped? Is EMIS A Scam? Check out the insider trade report here. Read Full Report: Geron Corporation (GERN): GERN is down $0.43 at $1.77, a loss of 19.55%. Shares of Geron fell in the morning on Nov 15, 2011 after the company said it would drop stem cells and focus on cancer. The company will also cut 66 jobs. Check out the latest report here. Read Full Report: Towerstream Corporation (TWER): Observed abnormal increase in trade volume. Over 3.71 million shares traded on Nov 15, 2011 which was 10 times higher than the average trade volume. TWER reported Q3 EPS of ($0.05), One cent worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.78 million versus the consensus estimate of $6.8 million. Towerstream sees Q4 2011 revenue of $7.0 to $7.1 million, versus the consensus of $7.25 million; see if CEO, CFO, and Directors in POSC are trading the stock now. Read Full Report: Today Pennystocksinsiders.com released other research reports for: BioSante Pharmaceuticals, Inc. (BPAX): Read Full Report: Syntroleum Corp (SYNM): Read Full Report: Sunwin International Neutraceuticals Inc (SUWN): Read Full Report: More Individual Stock Reports & Sector Reports: Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission. About Pennystocksinsiders.com: Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research. Important Disclaimer:Please visit for details. SOURCE Pennystocksinsiders.com Copyright (C) 2011 PR Newswire. All rights reserved